SLE/CLE TULIP-1 SLEにおけるアニフロルマブの有用性 Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, pha... 2021.12.07 SLE/CLE免疫膠原病内科
SLE/CLE ループス腎炎に対するべリムマブ投与の有用性について Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis N Engl J Med. 2020 Sep 17;383(12):1117-1128. ... 2021.02.16 SLE/CLE免疫膠原病内科